Corteva vs Ambev
This page compares Corteva and Ambev, outlining their business models, financial performance, and market context to provide a neutral, accessible view of their strategies. It highlights key differences and similarities without speculation. Educational content, not financial advice.
This page compares Corteva and Ambev, outlining their business models, financial performance, and market context to provide a neutral, accessible view of their strategies. It highlights key difference...
Why It's Moving
CTVA Faces Analyst Caution Amid Insider Selling and Recent Revenue Miss
- Insider Brian Titus sold 8,311 shares for $636,000 on Feb. 20, slashing his position by 50%, signaling possible concerns over near-term performance.
- Q4 revenue of $3.91 billion missed estimates by over 7%, down 1.7% year-over-year, pressuring margins in a crop protection segment facing pricing declines in key markets.
- Mixed analyst moves include JPMorgan's downgrade to neutral with a $77 target, contrasting upbeat targets like Jefferies' $95, amid FY2026 EPS guidance of $3.45-$3.70.
Ambev Shines as Growth Darling Amid Upward Earnings Revisions and Stellar Sales Outlook
- Earnings estimates for the current year jumped 2.8% over the past month, signaling strong investor confidence in Ambev's profit trajectory well above the 1.1% industry average.
- Sales growth forecast at 13.3% crushes the sector's -0.1% decline, highlighting Ambev's ability to expand revenue in tough conditions.
- Zacks Growth Score of B combined with Rank #2 reflects promising revisions and efficiency, making it a standout for growth-focused portfolios.
CTVA Faces Analyst Caution Amid Insider Selling and Recent Revenue Miss
- Insider Brian Titus sold 8,311 shares for $636,000 on Feb. 20, slashing his position by 50%, signaling possible concerns over near-term performance.
- Q4 revenue of $3.91 billion missed estimates by over 7%, down 1.7% year-over-year, pressuring margins in a crop protection segment facing pricing declines in key markets.
- Mixed analyst moves include JPMorgan's downgrade to neutral with a $77 target, contrasting upbeat targets like Jefferies' $95, amid FY2026 EPS guidance of $3.45-$3.70.
Ambev Shines as Growth Darling Amid Upward Earnings Revisions and Stellar Sales Outlook
- Earnings estimates for the current year jumped 2.8% over the past month, signaling strong investor confidence in Ambev's profit trajectory well above the 1.1% industry average.
- Sales growth forecast at 13.3% crushes the sector's -0.1% decline, highlighting Ambev's ability to expand revenue in tough conditions.
- Zacks Growth Score of B combined with Rank #2 reflects promising revisions and efficiency, making it a standout for growth-focused portfolios.
Investment Analysis
Corteva
CTVA
Pros
- Corteva has shown strong first half 2025 results with raised full-year guidance and a leading North American corn and soybean seed portfolio.
- It leads agricultural innovation with advanced trait technologies, gene editing, hybrid wheat, and digital farming solutions driving long-term growth.
- The company has a robust market position in seeds and crop protection with solid revenue growth and projected operational EBITDA of $3.6-3.8 billion in 2025.
Considerations
- Its stock trades at a premium valuation with a P/E ratio above sector average, indicating potentially limited upside relative to peers.
- Profit margins remain moderate with net margin around 8.16%, which may limit profitability compared to industry standards.
- Recent insider selling and volatility in the stock price pose potential execution and market sentiment risks despite positive earnings.
Ambev
ABEV
Pros
- Ambev is the leading brewer in Latin America with a strong brand portfolio including Brahma, Skol, and Antarctica, offering wide regional market penetration.
- It benefits from consistent cash flow generation supported by high operating margins and effective cost control in a stable beverage sector.
- The company has exposure to growing emerging markets with potential to capitalise on increasing beer and soft drink consumption trends.
Considerations
- Ambev faces regulatory and macroeconomic risks such as tax changes, inflation, and currency fluctuations in Latin American markets.
- The beverage industry is highly competitive and cyclical, exposing Ambev to demand fluctuations and pricing pressure.
- Growth prospects could be constrained by saturation in key markets and limited diversification beyond alcoholic and non-alcoholic beverages.
Related Market Insights
Brazil's Global Champions: A Smarter Way to Invest in Latin America's Largest Economy
Invest in Brazil's economic growth through global companies with significant operations. Mitigate currency risk & capture long-term potential with Nemo's Brazil Global Champions Neme.
Aimee Silverwood | Financial Analyst
October 8, 2025
Related Market Insights
Brazil's Global Champions: A Smarter Way to Invest in Latin America's Largest Economy
Invest in Brazil's economic growth through global companies with significant operations. Mitigate currency risk & capture long-term potential with Nemo's Brazil Global Champions Neme.
Aimee Silverwood | Financial Analyst
October 8, 2025
Corteva (CTVA) Next Earnings Date
Corteva will release its first quarter 2026 earnings on Tuesday, May 5, 2026 after the market close, with a live webcast to follow on Wednesday, May 6, 2026 at 9:00 a.m. Eastern Time. The Q1 2026 earnings report will cover the company's financial performance for the first quarter of the year. Analysts are currently projecting an EPS of $1.16 for this quarter. This earnings announcement represents a regular quarterly reporting cadence for the agricultural company.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) is scheduled to report its next earnings on May 5, 2026, covering the Q1 2026 results. The company's earnings report will be released before market open, with consensus expectations for earnings per share around $0.04. Based on historical patterns, Ambev typically reports quarterly earnings in May, August, October, and February. Investors should monitor the company's investor relations website for official confirmation and any updates to the scheduled release date.
Corteva (CTVA) Next Earnings Date
Corteva will release its first quarter 2026 earnings on Tuesday, May 5, 2026 after the market close, with a live webcast to follow on Wednesday, May 6, 2026 at 9:00 a.m. Eastern Time. The Q1 2026 earnings report will cover the company's financial performance for the first quarter of the year. Analysts are currently projecting an EPS of $1.16 for this quarter. This earnings announcement represents a regular quarterly reporting cadence for the agricultural company.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) is scheduled to report its next earnings on May 5, 2026, covering the Q1 2026 results. The company's earnings report will be released before market open, with consensus expectations for earnings per share around $0.04. Based on historical patterns, Ambev typically reports quarterly earnings in May, August, October, and February. Investors should monitor the company's investor relations website for official confirmation and any updates to the scheduled release date.
Which Baskets Do They Appear In?
Brazil Investment Through Global Partners 2025
For Brazilians, investing in global companies with strong local operations may offer a way to manage domestic economic risks and currency fluctuations. This basket provides exposure to leading US and EU-listed blue-chip corporations that are deeply integrated into the Brazilian economy.
Published: October 8, 2025
Explore BasketWhich Baskets Do They Appear In?
Brazil Investment Through Global Partners 2025
For Brazilians, investing in global companies with strong local operations may offer a way to manage domestic economic risks and currency fluctuations. This basket provides exposure to leading US and EU-listed blue-chip corporations that are deeply integrated into the Brazilian economy.
Published: October 8, 2025
Explore BasketBuy CTVA or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Corteva vs Kimberly-Clark
A neutral Corteva vs Kimberly-Clark stock comparison focusing on business models, financial performance and market context to guide research.
Corteva vs Coca-Cola Europacific Partners
A factual Corteva vs Coca-Cola Europacific Partners comparison of business models, financial performance and market context to help readers understand each company's operations.
Coca-Cola Europacific Partners vs Ambev
A neutral Coca-Cola Europacific Partners vs Ambev stock comparison, outlining business models, financials, and regional exposure to help readers research further.